Sorafenib Plus Chemotherapy Significantly Prolongs Progression-Free Survival in Advanced Breast Cancer Patients

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2009年 / 23卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：931 / 931
页数：1
相关论文
共 50 条
  • [1] ELACESTRANT PROLONGS PROGRESSION-FREE SURVIVAL IN ADVANCED BREAST CANCER
    不详
    [J]. CANCER DISCOVERY, 2022, 12 (07) : 1609 - 1609
  • [2] Osimertinib prolongs progression-free lung cancer survival after chemotherapy
    Fillon, Mike
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2024, 74 (05) : 402 - 404
  • [3] Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patients
    Feng, Yu-Min
    Feng, Chin-Wen
    Lu, Chin-Li
    Lee, Ming-Yang
    Chen, Chi-Yi
    Chen, Solomon Chih-Cheng
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 336 - 342
  • [4] Progression-free survival as a surrogate endpoint in advanced breast cancer
    Miksad, Rebecca A.
    Zietemann, Vera
    Gothe, Raffaella
    Schwarzer, Ruth
    Conrads-Frank, Annette
    Schnell-Inderst, Petra
    Stollenwerk, Bjoern
    Siebert, Uwe
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2008, 24 (04) : 371 - 383
  • [5] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    [J]. HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [6] Bevacizumab 'prolongs progression-free survival'
    Saul, Helen
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (12) : 2136 - 2136
  • [7] Baseline level of circulating endothelial progenitors predicts progression-free survival and overall survival in advanced hepatocellular carcinoma patients treated with sorafenib plus metronomic chemotherapy
    Shao, Yu-Yun
    Lin, Zhong-Zhe
    Chen, Te-Jung
    Chang, Dwan-Ying
    Hsu, Chiun
    Shen, Ying-Chun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    [J]. CANCER RESEARCH, 2009, 69
  • [8] <bold>Sorafenib against TACE: Significantly better progression-free Survival</bold>
    Hofmann-Assmus, Marion
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (10): : 936 - 936
  • [9] IN ADVANCED/METASTATIC BREAST CANCER, IS PROGRESSION-FREE SURVIVAL A SURROGATE OUTCOME?
    Franca, A. C.
    Schroeder, L.
    Padilla, M.
    Meirelles, I
    Silva, A. S.
    Magliano, C.
    Santos, M.
    [J]. VALUE IN HEALTH, 2020, 23 : S477 - S478
  • [10] Targeted therapy based on the genetic alterations prolongs the progression-free survival of patients with advanced biliary tract cancer
    Feng, F.
    Cheng, Q.
    Zhang, D.
    Li, B.
    Qin, H.
    Xu, C.
    Han, M.
    Yu, Y.
    Li, Z.
    Li, J-Y.
    Qiu, Z.
    Xiong, L.
    Liu, C.
    Li, F.
    Yi, B.
    Jiang, X.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
12345